Ads
related to: Pfizer
Search results
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 2 days agoPfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported ...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock | The Motley...
The Motley Fool· 5 days agoPfizer (PFE -0.21%) stock has struggled over the past year, losing around 28% of its value. Its...
Microsoft, Amazon, Pfizer, and others are investing a record $16 billion in France
Quartz· 4 days agoMicrosoft, Amazon, Pfizer, and other corporations announced Monday that they are investing a record...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 9 hours ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
WSAU Wausau· 2 days ago(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 2 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 5 days agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe UK's National Health Service (NHS) has introduced Pfizer's tafamidis for transthyretin...